• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE Back to Search Results
Model Number 7300TFX
Device Problems Perivalvular Leak (1457); Insufficient Information (3190); Central Regurgitation (4068)
Patient Problems Chest Pain (1776); Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
Event Date 01/08/2024
Event Type  Injury  
Event Description
It was reported that a patient with a 29mm mitral valve is being evaluated for a valve-in-valve procedure after an implant duration of 3 years, 8 months due to unknown reasons.
 
Manufacturer Narrative
Surgical/percutaneous intervention is indicated or performed, or harm occurred due to the device, or there is a device malfunction that could cause or contribute to a serious injury.This event is considered a serious injury.The device was not returned for evaluation, as it remains implanted.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
 
Manufacturer Narrative
H10: additional narratives: updated b5, b7, and h6 per new information received.
 
Event Description
It was reported that a patient with a 7300tfx 29mm mitral valve is being evaluated for a valve-in-valve procedure after an implant duration of 3 years, 8 months due to worsening regurgitation and moderate-to-severe perivalvular leak.The patient presented with nyha class iii, sob, and chest pressure.
 
Event Description
It was reported that a patient with a 7300tfx 29mm mitral valve underwent a valve-in-valve procedure after an implant duration of 3 years, 8 months due to worsening regurgitation and moderate-to-severe perivalvular leak.The patient presented with nyha class iii, sob, and chest pressure.A 29mm 9600tfx was implanted successfully.
 
Manufacturer Narrative
A definitive root cause cannot be conclusively determined; however, patient and/or procedural factors likely caused or contributed.The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
one edwards way
mle fl2- office m2013
irvine, CA 92614
9492506615
MDR Report Key18624949
MDR Text Key334340800
Report Number2015691-2024-00721
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860057
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/30/2023
Device Model Number7300TFX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/08/2024
Initial Date FDA Received02/01/2024
Supplement Dates Manufacturer Received02/02/2024
02/27/2024
Supplement Dates FDA Received02/27/2024
03/13/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/31/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age71 YR
Patient SexMale
-
-